Skip to content
  • Saturday, 12 September 2026
  • 6:38 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Earendil Labs Secures $787 Million to Accelerate AI-Driven Drug Discovery and Expand Robust Pipeline
Pharmaceutical R&D

Earendil Labs Secures $787 Million to Accelerate AI-Driven Drug Discovery and Expand Robust Pipeline

Teuku Ryan Mar 23, 2026 0

Earendil Labs, a burgeoning biotechnology firm at the forefront of artificial intelligence (AI)-powered drug discovery, has announced a significant financial…

Read More
Laboratory Automation & Robotics

Agentic AI-powered literature reviews: Reduce research burdens and accelerate insights

Lana Keisha Mar 23, 2026 0

The landscape of scientific research, particularly in drug development and healthcare, is undergoing a profound transformation driven by the advent…

Read More
Advanced Materials Science

Cambridge Researchers Unveil Light-Driven Chemical Breakthrough to Accelerate Sustainable Drug Development

Nila Kartika Wati Mar 21, 2026 0

Researchers at the University of Cambridge have pioneered a transformative chemical technique that utilizes visible light to modify complex drug…

Read More
Pharmaceutical R&D

UK Government Overhauls Medicine Regulation to Accelerate Patient Access and Boost Life Sciences Sector

Teuku Ryan Mar 19, 2026 0

The United Kingdom is set to revolutionize its medicine regulation framework, a move poised to significantly expedite patient access to…

Read More

Posts pagination

1 2 3
Science News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921Science News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921Scientists Unveil Proton Shuttle Mechanism for Controlling Triplet Energy Transfer in Quantum Dot SystemsThe Long Shadow of September 11: Twenty-Five Years of Health Consequences for Survivors and Responders
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
The oral exposure challenge in PROTACs: What drug developers need to solve earlyAttention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological LandscapeHarmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum InformationSolstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Sep 12, 2026
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026
Advanced Materials Science
Harmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
Nila Kartika Wati Sep 12, 2026
Pharmaceutical R&D
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Teuku Ryan Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ